［ Technical Info ］
Technologies for next-generation drug modalities
Better Health and Drugs through Oligonucleotide and Peptide APIs
Analytical Method Development
We support the development and improvement of API manufacturing processes, scale-up technology, and analytical methods.
Support for DDS Research and Drug Discovery
We develop drug delivery systems (DDS) for oligonucleotide and peptide drugs and next-generation nucleic acid technologies.
As a CDMO
Nippon Shokubai offers value not only as a chemical product manufacturer but also as a solution provider. With our experienced team, comprehensive research facilities, and active technology exchange, we help our customers accelerate their R&D activities and develop effective manufacturing strategies.
- Technical Info
Paper published in Tetrahedron Letters on phosphorothioate oligonucleotides
Participated as a finalist in Citeline Pharma Intelligence Awards Japan 2023
Notice of Luncheon Pitch at “EU-Japan Biotech &Pharma Partnering Conference 2023“
Notice of Exhibit at “TIDES EUROPE 2023“
Providing Prosperity and Comfort to People and Society
Nippon Shokubai is a chemical company that provides materials and solutions needed by people and society.